Cross Country Healthcare, Inc. (CCRN)
USD 17.89
(-0.06%)
USD 17.89
(-0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.01 Billion | 2.8 Billion | 1.67 Billion | 836.41 Million | 822.22 Million | 816.48 Million |
| Cost of Revenue | 1.58 Billion | 2.17 Billion | 1.3 Billion | 633.68 Million | 618.21 Million | 606.92 Million |
| Gross Profit | 432.06 Million | 627.68 Million | 374.99 Million | 202.73 Million | 204 Million | 209.56 Million |
| Operating Expenses | 337.69 Million | 336.78 Million | 225.14 Million | 186.48 Million | 196.03 Million | 192.01 Million |
| Selling, General and Administrative Expenses | 314.95 Million | 324.2 Million | 215.29 Million | 173.8 Million | 181.95 Million | 180.23 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 22.74 Million | 12.57 Million | 9.85 Million | 12.67 Million | 14.07 Million | 418 Thousand |
| Cost and Expenses | 1.9 Billion | 2.51 Billion | 1.52 Billion | 820.16 Million | 814.24 Million | 798.93 Million |
| Operating Income | 112.71 Million | 273.1 Million | 139.3 Million | 15.97 Million | 8.04 Million | -12.88 Million |
| Interest Expense | 8.09 Million | 14.39 Million | 6.86 Million | 2.89 Million | 5.3 Million | 5.65 Million |
| Income Tax Expense | 30.26 Million | 67.86 Million | 1.2 Million | -188 Thousand | 31.73 Million | -2.47 Million |
| Earnings before Tax | 102.89 Million | 256.32 Million | 133.2 Million | -12.33 Million | -24.21 Million | -18.19 Million |
| Net Income | 72.63 Million | 188.46 Million | 132 Million | -12.14 Million | -55.94 Million | -16.95 Million |
| Earnings Per Share Basic | 2.07 | 5.09 | 3.60 | -0.34 | -1.56 | -0.48 |
| Earnings Per Share Diluted | 2.05 | 5.02 | 3.53 | -0.34 | -1.56 | -0.48 |
| Weighted Average Shares Outstanding | 35.15 Million | 37.01 Million | 36.68 Million | 36.08 Million | 35.81 Million | 35.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.47 Million | 37.53 Million | 37.39 Million | 36.08 Million | 35.81 Million | 35.65 Million |
| Gross Margin | 0.21 | 0.22 | 0.22 | 0.24 | 0.25 | 0.26 |
| EBIT Margin | 0.06 | 0.11 | 0.10 | 0.03 | 0.03 | 0.04 |
| Profit Margin | 0.04 | 0.07 | 0.08 | -0.01 | -0.07 | -0.02 |
| EBITDA | 129.33 Million | 285.14 Million | 152.35 Million | 2.41 Million | -4.83 Million | -761 Thousand |
| Earnings Before Tax Margin | 0.06 | 0.10 | 0.08 | 0.02 | 0.01 | -0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 339.77 Million | 379.17 Million | 2.01 Billion | 414.03 Million | 442.29 Million | 540.69 Million |
| Cost of Revenue | 273.68 Million | 306.51 Million | 1.58 Billion | 328.01 Million | 344.93 Million | 417.55 Million |
| Gross Profit | 66.08 Million | 72.65 Million | 432.06 Million | 86.01 Million | 97.35 Million | 123.13 Million |
| Operating Expenses | 79.11 Million | 64.54 Million | 314.95 Million | 323.54 Million | 74.16 Million | 417.55 Million |
| Selling, General and Administrative Expenses | 79.11 Million | 64.54 Million | - | 67.56 Million | 69.62 Million | 78.93 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 212 Thousand | 1.23 Million | -2000.00 | 255.98 Million | -134 Thousand | 338.61 Million |
| Cost and Expenses | 352.8 Million | 371.06 Million | 1.9 Billion | 323.54 Million | 419.09 Million | 417.55 Million |
| Operating Income | -13.03 Million | 8.11 Million | 117.11 Million | 13.42 Million | 20.3 Million | 35.18 Million |
| Interest Expense | 568 Thousand | 462 Thousand | 8.09 Million | 586 Thousand | 669 Thousand | 3.14 Million |
| Income Tax Expense | -3.51 Million | 997 Thousand | 30.26 Million | 3.93 Million | 6.68 Million | 8.96 Million |
| Earnings before Tax | -19.56 Million | 3.68 Million | 102.89 Million | 12.96 Million | 19.5 Million | 30.3 Million |
| Net Income | -16.05 Million | 2.69 Million | 72.63 Million | 9.03 Million | 12.81 Million | 21.34 Million |
| Earnings Per Share Basic | -0.47 | 0.08 | - | 0.26 | 0.37 | 0.60 |
| Earnings Per Share Diluted | -0.47 | 0.08 | - | 0.26 | 0.36 | 0.60 |
| Weighted Average Shares Outstanding | 33.96 Million | 34.21 Million | 35.15 Million | 34.48 Million | 34.95 Million | 35.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.96 Million | 34.59 Million | 35.47 Million | 34.68 Million | 35.15 Million | 35.52 Million |
| Gross Margin | 0.19 | 0.19 | 0.21 | 0.21 | 0.22 | 0.23 |
| EBIT Margin | -0.02 | 0.03 | - | 0.04 | 0.06 | 0.07 |
| Profit Margin | -0.05 | 0.01 | 0.04 | 0.02 | 0.03 | 0.04 |
| EBITDA | -8.31 Million | 12.75 Million | - | 18.02 Million | 27.59 Million | 37.88 Million |
| Earnings Before Tax Margin | -0.04 | 0.02 | 0.06 | 0.03 | 0.05 | 0.07 |
AMXB
AURE
IPSEY
CMEIF
ZEUCF
BAH